Isolated congenital breast hypoplasia/aplasia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:180188OMIM:113700Q83.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Isolated congenital breast hypoplasia/aplasia is a rare developmental anomaly of the breast in which one or both breasts fail to develop normally (hypoplasia) or are completely absent (aplasia) from birth. This condition is classified under congenital absence of the breast (ICD-10: Q83.0) and occurs as an isolated finding, meaning it is not associated with other congenital malformations such as limb defects (as seen in Poland syndrome) or ectodermal dysplasia syndromes. The condition affects the integumentary system, specifically the mammary gland and associated breast tissue, and may involve absence or underdevelopment of the nipple and areola as well. It can be unilateral or bilateral and may affect males or females, though it is most clinically significant in females due to the functional and cosmetic importance of breast tissue. The key clinical features include absent or markedly underdeveloped breast tissue, which becomes most apparent during puberty when normal breast development would be expected. In females, this can lead to inability to breastfeed and significant psychosocial distress. The underlying cause in isolated cases is not fully understood, and both sporadic and familial occurrences have been reported, suggesting possible genetic heterogeneity. Some familial cases have suggested autosomal dominant inheritance with variable expressivity, but the genetic basis remains largely uncharacterized. There is no medical treatment that can induce natural breast development in affected individuals. Management is primarily surgical, with breast reconstruction or augmentation using prosthetic implants or autologous tissue transfer being the main therapeutic options. Psychological support and counseling are also important components of care, particularly for adolescents and young women affected by this condition.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Isolated congenital breast hypoplasia/aplasia.

View clinical trials →

No actively recruiting trials found for Isolated congenital breast hypoplasia/aplasia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Isolated congenital breast hypoplasia/aplasia community →

No specialists are currently listed for Isolated congenital breast hypoplasia/aplasia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Isolated congenital breast hypoplasia/aplasia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Isolated congenital breast hypoplasia/aplasiaForum →

No community posts yet. Be the first to share your experience with Isolated congenital breast hypoplasia/aplasia.

Start the conversation →

Latest news about Isolated congenital breast hypoplasia/aplasia

No recent news articles for Isolated congenital breast hypoplasia/aplasia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Isolated congenital breast hypoplasia/aplasia

What is Isolated congenital breast hypoplasia/aplasia?

Isolated congenital breast hypoplasia/aplasia is a rare developmental anomaly of the breast in which one or both breasts fail to develop normally (hypoplasia) or are completely absent (aplasia) from birth. This condition is classified under congenital absence of the breast (ICD-10: Q83.0) and occurs as an isolated finding, meaning it is not associated with other congenital malformations such as limb defects (as seen in Poland syndrome) or ectodermal dysplasia syndromes. The condition affects the integumentary system, specifically the mammary gland and associated breast tissue, and may involve

At what age does Isolated congenital breast hypoplasia/aplasia typically begin?

Typical onset of Isolated congenital breast hypoplasia/aplasia is neonatal. Age of onset can vary across affected individuals.